Concept information
Preferred term
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Type
-
mesh:Descriptor
Definition
- A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
Broader concept
Entry terms
- 28289-54-5 (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
- 9P21XSP91P
- MPTP
- N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
28289-54-5 (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
-
9P21XSP91P
-
MPTP
-
Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-
URI
http://data.loterre.fr/ark:/67375/JVR-K1ZR7M1C-Q
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}